Home » Par Pharmaceutical Receives Final Approval to Market Tretinoin Capsules
Par Pharmaceutical Receives Final Approval to Market Tretinoin Capsules
Par Pharmaceutical announced that its operating subsidiary, Anchen Pharmaceuticals, has received final approval from the FDA for its ANDA for tretinoin capsules, 10 mg.
The Sacramento Bee
The Sacramento Bee
Upcoming Events
-
07May
-
14May
-
30May